If all goes according to plan, healthcare facilities in the next few years could begin purchasing 3D-printed bone implants that are being developed by a Farmington-based startup called A.D.A.M.
The company, which operates out of office and lab space inside UConn’s Technology Incubation Program (TIP), received pre-approval from the Food and Drug Administration in July to begin testing its implants on animals, said CEO Denys Gurak, who is eyeing a 2023 marketplace launch.
"We've been trying outreach to some top U.S. insurance companies," said Gurak, who previously led pharmaceutical manufacturing regulation at the State Administration of Ukraine on Medicinal Products, Ukraine's equivalent to the FDA. "They will be the primary payer for the treatment we provide, so we want to do this early rather than later."